As part of a continuing effort to tackle issues of major social concern, this 280th conference of internationally recognized experts from the fields of molecular biology, medicine, philosophy, theology, and the law looks into the scientific, legal, ethical, social, and economic issues confronting man and his ability to map and sequence the human genome. A wide variety of subjects are covered, including prenatal diagnosis, advances in the genetics of psychiatric disorders, the problems associated with polygenic disease, and the limits to genetic intervention in humans. The symposium also discusses genetic manipulation, commercial exploitation, and legal implications.
表中的内容
Partial table of contents:
The Human Genome: The Nature of the Enterprise (S. Brenner).
Prenatal Diagnosis: Current Approaches and Future Trends (J.
Bell).
The Use of Genetic Markers for Personal Identification and the
Analysis of Family Relationships (P. Debenham).
Recent Advances in the Genetics of Psychiatric Disorder (H.
Gurling).
Limits to Genetic Intervention in Humans: Somatic and Germline
(B. Davis).
Human Genetic Information: The Legal Implications (D.
Brahams).
Commercial Exploitation of the Human Genome: What Are the
Problems?
(N. Carey & P. Crawley).
Religious Aspects of Human Genetic Information (R. Kimura).
Who Might I Have Been?
(B. Williams).
Human Genome Analysis and the Concept of Human Nature (M.
Charlesworth).
Index of Contributors.
Subject Index.
关于作者
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.